Alistair Connell

Alistair Connell

Auto-generated profile, based on publicly available information

Alistair Connell

Digital Health Section, The Royal Society of Medicine, London, UK

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2019 in Nature
Verified
Journal Article
Closed access
PDF file
NTNenad Tomašev
Nenad Tomašev
XGXavier Glorot
Xavier Glorot
JRJack W. Rae
Jack W. Rae
MZMichal Zielinski
Michal Zielinski
HAHarry Askham
Harry Askham
SMShakir Mohamed
Shakir Mohamed

23 October 2020 in Hepatology
Verified
Journal Article
Closed access
PDF file
JAJoseph C. Ahn
Joseph C. Ahn
ACAlistair Connell
Alistair Connell
DSDouglas A. Simonetto
Douglas A. Simonetto
CHCian Hughes
Cian Hughes
VSVijay H. Shah
Vijay H. Shah

5 May 2021 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
NTNenad Tomašev
Nenad Tomašev
NHNatalie Harris
Natalie Harris
SBSebastien Baur
Sebastien Baur
AMAnne Mottram
Anne Mottram
XGXavier Glorot
Xavier Glorot
SMShakir Mohamed
Shakir Mohamed

26 February 2025 in Nature
Verified
Journal Article
Open access
PDF file
KSKamal Shah
Kamal Shah
AWAnran Wang
Anran Wang
YCYiwen Chen
Yiwen Chen
JMJitender Munjal
Jitender Munjal
SCSumeet Chhabra
Sumeet Chhabra
JSJake Sunshine
Jake Sunshine
Out-of-hospital cardiac arrest is a time-sensitive emergency that requires prompt identification and intervention: sudden, unwitnessed cardiac arrest is nearly unsurvivable1–3. A cardinal sign of cardiac arrest is sudden loss of pulse4. Automated biosensor detection of unwitnessed cardiac arrest, and dispatch of medical assistance, may improve survivability given the significant prognostic role of time3,5, but only if the false positive burden on public emergency medical systems is minimized5–7. Here we show that a multimodal, machine learning-based algorithm on a smartwatch can reach performance thresholds making it deployable at societal scale. First, using photoplethysmography (PPG), we show that wearable PPG measurements of peripheral pulselessness (induced via an arterial occlusion model) manifest similarly to pulselessness caused by a common cardiac arrest arrhythmia, ventricular fibrillation (VF). Based on the similarity of the PPG signal (from VF or arterial occlusion), we developed and validated a loss of pulse detection algorithm using data from peripheral pulselessness and free-living conditions. Once developed, we evaluated the end-to-end algorithm prospectively: there was 1 unintentional emergency call per 21.67 user-years across two prospective studies; the sensitivity was 67.23% (95% confidence interval, 64.32%–70.05%) in a prospective arterial occlusion cardiac arrest simulation model. These results suggest a new opportunity, deployable at scale, for wearable-based detection of sudden loss of pulse while minimizing societal costs of excess false detections7.

31 July 2019 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
ACAlistair Connell
Alistair Connell
HMHugh Montgomery
Hugh Montgomery
PMPeter Martin
Peter Martin
CNClaire Nightingale
Claire Nightingale
OSOmid Sadeghi-Alavijeh
Omid Sadeghi-Alavijeh
RRRosalind Raine
Rosalind Raine
We developed a digitally enabled care pathway for acute kidney injury (AKI) management incorporating a mobile detection application, specialist clinical response team and care protocol. Clinical outcome data were collected from adults with AKI on emergency admission before (May 2016 to January 2017) and after (May to September 2017) deployment at the intervention site and another not receiving the intervention. Changes in primary outcome (serum creatinine recovery to ≤120% baseline at hospital discharge) and secondary outcomes (30-day survival, renal replacement therapy, renal or intensive care unit (ICU) admission, worsening AKI stage and length of stay) were measured using interrupted time-series regression. Processes of care data (time to AKI recognition, time to treatment) were extracted from casenotes, and compared over two 9-month periods before and after implementation (January to September 2016 and 2017, respectively) using pre–post analysis. There was no step change in renal recovery or any of the secondary outcomes. Trends for creatinine recovery rates (estimated odds ratio (OR) = 1.04, 95% confidence interval (95% CI): 1.00–1.08, p = 0.038) and renal or ICU admission (OR = 0.95, 95% CI: 0.90–1.00, p = 0.044) improved significantly at the intervention site. However, difference-in-difference analyses between sites for creatinine recovery (estimated OR = 0.95, 95% CI: 0.90–1.00, p = 0.053) and renal or ICU admission (OR = 1.06, 95% CI: 0.98–1.16, p = 0.140) were not significant. Among process measures, time to AKI recognition and treatment of nephrotoxicity improved significantly (p < 0.001 and 0.047 respectively).

15 July 2019 in Journal of Medical Internet Research
Verified
Journal Article
Open access
ACAlistair Connell
Alistair Connell
GBGeorgia B Black
Georgia B Black
HMHugh Montgomery
Hugh Montgomery
PMPeter Martin
Peter Martin
CNClaire Nightingale
Claire Nightingale
RRRosalind Raine
Rosalind Raine
Background: One reason for the introduction of digital technologies into health care has been to try to improve safety and patient outcomes by providing real-time access to patient data and enhancing communication among health care professionals. However, the adoption of such technologies into clinical pathways has been less examined, and the impacts on users and the broader health system are poorly understood. We sought to address this by studying the impacts of introducing a digitally enabled care pathway for patients with acute kidney injury (AKI) at a tertiary referral hospital in the United Kingdom. A dedicated clinical response team—comprising existing nephrology and patient-at-risk and resuscitation teams—received AKI alerts in real time via Streams, a mobile app. Here, we present a qualitative evaluation of the experiences of users and other health care professionals whose work was affected by the implementation of the care pathway. Objective: The aim of this study was to qualitatively evaluate the impact of mobile results viewing and automated alerting as part of a digitally enabled care pathway on the working practices of users and their interprofessional relationships. Methods: A total of 19 semistructured interviews were conducted with members of the AKI response team and clinicians with whom they interacted across the hospital. Interviews were analyzed using inductive and deductive thematic analysis. Results: The digitally enabled care pathway improved access to patient information and expedited early specialist care. Opportunities were identified for more constructive planning of end-of-life care due to the earlier detection and alerting of deterioration. However, the shift toward early detection also highlighted resource constraints and some clinical uncertainty about the value of intervening at this stage. The real-time availability of information altered communication flows within and between clinical teams and across professional groups. Conclusions: Digital technologies allow early detection of adverse events and of patients at risk of deterioration, with the potential to improve outcomes. They may also increase the efficiency of health care professionals’ working practices. However, when planning and implementing digital information innovations in health care, the following factors should also be considered: the provision of clinical training to effectively manage early detection, resources to cope with additional workload, support to manage perceived information overload, and the optimization of algorithms to minimize unnecessary alerts.